1,264
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

Understanding reasons for treatment interruption amongst patients on antiretroviral therapy – A qualitative study at the Lighthouse Clinic, Lilongwe, Malawi

, , , , &
Article: 24795 | Received 29 Apr 2014, Accepted 04 Sep 2014, Published online: 30 Sep 2014

Figures & data

Fig. 1 Study population. Eligibility criteria were ≥15 years, documented treatment interruption of ≥21 days (between January 2008 and November 2009), resumption of ART. In total, patient characteristics of 347 patients were analysed, 147 B2C forms were entered into an MSAccess database and 26 in-depth interviews were conducted for descriptive analysis and to gain a further understanding of reasons for treatment interruption.

ART: Antiretroviral therapy; B2C: Back-to-Care; EDS: Electronic data system; LTFU: Lost-to-Follow up

Fig. 1 Study population. Eligibility criteria were ≥15 years, documented treatment interruption of ≥21 days (between January 2008 and November 2009), resumption of ART. In total, patient characteristics of 347 patients were analysed, 147 B2C forms were entered into an MSAccess database and 26 in-depth interviews were conducted for descriptive analysis and to gain a further understanding of reasons for treatment interruption.ART: Antiretroviral therapy; B2C: Back-to-Care; EDS: Electronic data system; LTFU: Lost-to-Follow up

Fig. 2 Reasons for treatment interruption. Relative frequency of reasons for treatment interruption as stated by patients in the B2C form n=147; multiple reasons per patient possible. Additional categories exceeding the scope of the pre-defined categories were derived from the comment field and are marked with a star: *.

B2C: Back-to-Care.

Fig. 2 Reasons for treatment interruption. Relative frequency of reasons for treatment interruption as stated by patients in the B2C form n=147; multiple reasons per patient possible. Additional categories exceeding the scope of the pre-defined categories were derived from the comment field and are marked with a star: *.B2C: Back-to-Care.

Table 1 Respondents’ characteristics: In-depth interview (n=26)

Table 2 Factors supporting with drug adherence and retention in care in patients with documented treatment interruption (in-depth interviews; n=26)

Table 3 Reasons for treatment interruption (in-depth interviews; n=26)